Replies to post #82230 on $heff's $tation of $tocks & $olid DD

[$heff]

$EPZM Catalyst.."So in 2014 we will be finishing our Phase 1 clinical studies initiating clinical studies in the pediatric populations in May, which we’ve achieved. Have ongoing Phase 1 dose escalation studies in 6438 that we expect to complete this year and present the data in the second half of this year. And then two proof-of-concept studies one in non-hodgkin lymphoma patients and one in INI1-deficient tumors like synovial sarcoma."
-From latest quarterly transcript